Supplemental Guidance on Testing for Replication-Competent Retrovirus in Retroviral Vector-Based Gene Therapy Products and During Follow-Up of Patients in Clinical Trials Using Retroviral Vectors
Human Gene Therapy - United States
doi 10.1089/10430340150218440
Full Text
Open PDFAbstract
Available in full text
Date
February 10, 2001
Authors
Unknown
Publisher
Mary Ann Liebert Inc